tiprankstipranks
Trending News
More News >
Concord Healthcare Group Co., Ltd. Class H (HK:2453)
:2453
Hong Kong Market
Advertisement

Concord Healthcare Group Co., Ltd. Class H (2453) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Concord Healthcare Group Co., Ltd. Class H has a market cap or net worth of HK$1.99B. The enterprise value is HK$7.91B.
Market CapHK$1.99B
Enterprise ValueHK$7.91B

Share Statistics

Concord Healthcare Group Co., Ltd. Class H has 313,874,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding313,874,630
Owned by Insiders
Owned by Institutions

Financial Efficiency

Concord Healthcare Group Co., Ltd. Class H’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -7.16%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-7.16%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee684.84K
Profits Per Employee-781.70K
Employee Count567
Asset Turnover0.07
Inventory Turnover13.62

Valuation Ratios

The current PE Ratio of Concord Healthcare Group Co., Ltd. Class H is ―. Concord Healthcare Group Co., Ltd. Class H’s PEG ratio is -1.56.
PE Ratio
PS Ratio19.04
PB Ratio4.49
Price to Fair Value4.49
Price to FCF-14.78
Price to Operating Cash Flow-25.40
PEG Ratio-1.56

Income Statement

In the last 12 months, Concord Healthcare Group Co., Ltd. Class H had revenue of 388.31M and earned -443.22M in profits. Earnings per share was -0.62.
Revenue388.31M
Gross Profit-67.25M
Operating Income-371.21M
Pretax Income-485.85M
Net Income-443.22M
EBITDA-194.46M
Earnings Per Share (EPS)-0.62

Cash Flow

In the last 12 months, operating cash flow was -67.57M and capital expenditures 168.04M, giving a free cash flow of 100.47M billion.
Operating Cash Flow-67.57M
Free Cash Flow100.47M
Free Cash Flow per Share0.32

Dividends & Yields

Concord Healthcare Group Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.54
52-Week Price Change-84.96%
50-Day Moving Average3.59
200-Day Moving Average6.05
Relative Strength Index (RSI)29.70
Average Volume (3m)929.19K

Important Dates

Concord Healthcare Group Co., Ltd. Class H upcoming earnings date is Aug 28, 2025, Before Open (Confirmed).
Last Earnings DateMar 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date

Financial Position

Concord Healthcare Group Co., Ltd. Class H as a current ratio of 0.63, with Debt / Equity ratio of 209.80%
Current Ratio0.63
Quick Ratio0.60
Debt to Market Cap0.42
Net Debt to EBITDA-15.45
Interest Coverage Ratio-3.40

Taxes

In the past 12 months, Concord Healthcare Group Co., Ltd. Class H has paid -1.03M in taxes.
Income Tax-1.03M
Effective Tax Rate<0.01

Enterprise Valuation

Concord Healthcare Group Co., Ltd. Class H EV to EBITDA ratio is -53.47, with an EV/FCF ratio of -20.79.
EV to Sales26.78
EV to EBITDA-53.47
EV to Free Cash Flow-20.79
EV to Operating Cash Flow-55.91

Balance Sheet

Concord Healthcare Group Co., Ltd. Class H has HK$170.03M in cash and marketable securities with HK$3.23B in debt, giving a net cash position of -HK$3.06B billion.
Cash & Marketable SecuritiesHK$170.03M
Total DebtHK$3.23B
Net Cash-HK$3.06B
Net Cash Per Share-HK$9.75
Tangible Book Value Per ShareHK$1.50

Margins

Gross margin is -8.74%, with operating margin of -95.60%, and net profit margin of -114.14%.
Gross Margin-8.74%
Operating Margin-95.60%
Pretax Margin-125.12%
Net Profit Margin-114.14%
EBITDA Margin-50.08%
EBIT Margin-79.45%

Analyst Forecast

The average price target for Concord Healthcare Group Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-21.84%
EPS Growth Forecast-20.73%

Scores

Smart Score1
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis